{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:11:02Z","timestamp":1782249062458,"version":"3.54.5"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T00:00:00Z","timestamp":1466553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["22117502"],"award-info":[{"award-number":["22117502"]}]},{"name":"Program to Disseminate Tenure Tracking System from the Ministry of Science, Education, Culture, and Technology of Japan"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157580","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T07:25:43Z","timestamp":1466666743000},"page":"e0157580","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice"],"prefix":"10.1371","volume":"11","author":[{"given":"Noriko","family":"Suzuki-Kemuriyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsuzaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Kuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-iee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Yatoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Nakae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Yahagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of nonalcoholic fatty liver disease: a global perspective","volume":"28","author":"M Lazo","year":"2008","journal-title":"Semin Liver Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cld.2009.07.005","article-title":"Epidemiology and natural history of non-alcoholic steatohepatitis","volume":"13","author":"CK Argo","year":"2009","journal-title":"Clin Liver Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/hep.23659","article-title":"Fatty liver: think globally","volume":"51","author":"JE Everhart","year":"2010","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"JC Cohen","year":"2011","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"P Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"GC Farrell","year":"2006","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"G Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"G Targher","year":"2005","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2013.10.030","article-title":"Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology","volume":"232","author":"P Loria","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"CP Day","year":"1998","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Z Li","year":"2003","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.1158042","article-title":"Regulation of hepatic lipogenesis by the transcription factor XBP1","volume":"320","author":"AH Lee","year":"2008","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/db09-1403","article-title":"C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis","volume":"59","author":"AE Obstfeld","year":"2010","journal-title":"Diabetes"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"H Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref16","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","author":"E Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","article-title":"Lipotoxicity in the liver","volume":"5","author":"V Z\u00e1mb\u00f3","year":"2013","journal-title":"World J Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/hep.25932","article-title":"Elovl6 promotes nonalcoholic steatohepatitis","volume":"56","author":"T Matsuzaka","year":"2012","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"17604","DOI":"10.1038\/srep17604","article-title":"Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr(-\/-) mouse model","volume":"5","author":"M Kuba","year":"2015","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1505s","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases","volume":"83","author":"PC Calder","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMra1008153","article-title":"n-3 fatty acids in cardiovascular disease","volume":"364","author":"R De Caterina","year":"2011","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbalip.2011.10.011","article-title":"Fish oil\u2014how does it reduce plasma triglycerides?","volume":"1821","author":"GC Shearer","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"ref23","article-title":"Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial","author":"MA Nogueira","year":"2015","journal-title":"Clin Nutr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"35840","DOI":"10.1074\/jbc.274.50.35840","article-title":"A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids","volume":"274","author":"N Yahagi","year":"1999","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.hep.2003.09.028","article-title":"Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression","volume":"38","author":"M Sekiya","year":"2003","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"11681","DOI":"10.1074\/jbc.M109.096107","article-title":"Polyunsaturated fatty acids selectively suppress sterol regulatory element-binding protein-1 through proteolytic processing and autoloop regulatory circuit","volume":"285","author":"Y Takeuchi","year":"2010","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study","volume":"60","author":"E Scorletti","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"Chojkier M; EPE-A Study Group. No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"AJ Sanyal","year":"2014","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","article-title":"Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease","volume":"33","author":"E Scorletti","year":"2013","journal-title":"Annu Rev Nutr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S002966511500244X","article-title":"Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-\/- mice","volume":"75","author":"DB Jump","year":"2016","journal-title":"Proc Nutr Soc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mnfr.201500346","article-title":"Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA","volume":"60","author":"J Delarue","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3945\/jn.112.171322","article-title":"Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-\/-) mouse model of western diet-induced nonalcoholic steatohepatitis","volume":"143","author":"CM Depner","year":"2013","journal-title":"J Nutr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2131\/jts.38.379","article-title":"Eicosapentaenoic acid attenuates hepatic accumulation of cholesterol esters but aggravates liver injury and inflammation in mice fed a cholate-supplemented high-fat diet","volume":"38","author":"S Watanabe","year":"2013","journal-title":"J Toxicol Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nm1662","article-title":"Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance","volume":"13","author":"T Matsuzaka","year":"2007","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e69415","DOI":"10.1371\/journal.pone.0069415","article-title":"4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation","volume":"8","author":"A Ishikado","year":"2013","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1194\/jlr.M600177-JLR200","article-title":"Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity","volume":"47","author":"Y Wang","year":"2006","journal-title":"J Lipid Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.21874","article-title":"Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet","volume":"46","author":"N Matsuzawa","year":"2007","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"35931","DOI":"10.1074\/jbc.M306238200","article-title":"Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes","volume":"278","author":"A Pawar","year":"2003","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MOL.0b013e3282ffaf6a","article-title":"N-3 polyunsaturated fatty acid regulation of hepatic gene transcription","volume":"19","author":"DB Jump","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.plipres.2009.12.002","article-title":"The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice","volume":"49","author":"H Guillou","year":"2010","journal-title":"Prog Lipid Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MCO.0000000000000254","article-title":"Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis","volume":"19","author":"JY Zhang","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/hep.20093","article-title":"Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats","volume":"39","author":"JR Levy","year":"2004","journal-title":"Hepatology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2337\/db09-1554","article-title":"Antiobesity effect of eicosapentaenoic acid in high-fat\/high-sucrose diet-induced obesity: importance of hepatic lipogenesis","volume":"59","author":"A Sato","year":"2010","journal-title":"Diabetes"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"34213","DOI":"10.1074\/jbc.M707404200","article-title":"Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage","volume":"282","author":"V Puri","year":"2007","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"14355","DOI":"10.1074\/jbc.M708323200","article-title":"Fat-specific protein 27 regulates storage of triacylglycerol","volume":"283","author":"P Keller","year":"2008","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"P Puri","year":"2007","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/liv.12685","article-title":"Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis","volume":"35","author":"K Yamada","year":"2015","journal-title":"Liver Int"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1126\/science.6254151","article-title":"Prostaglandins, arachidonic acid, and inflammation","volume":"210","author":"FA Kuehl Jr.","year":"1980","journal-title":"Science"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation","volume":"220","author":"B Samuelsson","year":"1983","journal-title":"Science"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(86)90073-2","article-title":"Prostaglandins, thromboxanes, and leukotrienes in inflammation","volume":"80","author":"CL Malmsten","year":"1986","journal-title":"Am J Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","article-title":"The opposing effects of n-3 and n-6 fatty acids","volume":"47","author":"G Schmitz","year":"2008","journal-title":"Prog Lipid Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"JD Browning","year":"2004","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"LM Arterburn","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-511X-8-33","article-title":"Are all n-3 polyunsaturated fatty acids created equal?","volume":"8","author":"BM Anderson","year":"2009","journal-title":"Lipids Health Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T02:35:30Z","timestamp":1568082930000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157580"}},"subtitle":[],"editor":[{"given":"Herv\u00e9","family":"Guillou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,22]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157580","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,22]]}}}